Cy3 NHS Ester (Non-Sulfonated): Precision Protein & Organelle Labeling

Introduction: The Principle and Setup of Cy3 NHS Ester Labeling

The Cy3 NHS ester (non-sulfonated) is a versatile fluorescent dye for amino group labeling, widely used for covalent tagging of proteins, peptides, and oligonucleotides. As a member of the cyanine dye family, Cy3 NHS ester features a polymethine structure, enabling broad spectral coverage and high photostability. Its orange fluorescence—excitation at 555 nm and emission at 570 nm—makes it particularly suitable for multiplexed fluorescence microscopy and biomedical imaging applications, leveraging standard TRITC (Tetramethylrhodamine) filter sets.

Supplied as a solid and highly soluble in organic solvents (≥59 mg/mL in DMSO; ≥25.3 mg/mL in ethanol), Cy3 NHS ester (non-sulfonated) is engineered for robust performance in a wide range of labeling protocols. With an extinction coefficient of 150,000 M⁻¹cm⁻¹ and a quantum yield of 0.31, it delivers high detection sensitivity, making it an ideal protein labeling with Cy3 solution for demanding workflows. APExBIO, a trusted supplier, ensures product consistency and reliability, supporting reproducible experimental outcomes across the biomedical research spectrum.

Step-by-Step Workflow: Enhancing Labeling Protocols with Cy3 NHS Ester

1. Preparation and Solubilization

• Equilibrate Cy3 NHS ester (non-sulfonated) to room temperature before opening to avoid condensation.
• Dissolve the dye in anhydrous DMSO or DMF to prepare a concentrated stock solution (10–20 mM). Avoid water, as the dye is insoluble and may hydrolyze.
• For peptide or oligonucleotide labeling, ensure that the biomolecule is dissolved in a suitable buffer (e.g., 0.1 M sodium bicarbonate, pH 8.3) free from primary amines or reducing agents.

2. Labeling Reaction

• Add the Cy3 NHS ester stock to the biomolecule solution at a controlled molar ratio (typically 5–20:1, dye:biomolecule) to optimize labeling density.
• Incubate for 30–60 minutes at room temperature, protected from light.
• Quench excess NHS ester with a small amount of Tris or glycine (final concentration 20–50 mM).

3. Purification

• Remove unreacted dye via size-exclusion chromatography, desalting columns, or dialysis.
• Confirm labeling efficiency by measuring absorbance at 280 nm (protein) and 550–570 nm (dye), applying extinction coefficients to calculate the degree of labeling (DOL).

4. Storage

• Store labeled conjugates at 4°C in the dark; avoid long-term storage of dye solutions to prevent degradation.
• For unreacted dye, store powder at –20°C, protected from light, to retain activity for up to 24 months as recommended by APExBIO.

For further details on reproducibility and protocol optimization, the article "Cy3 NHS Ester (Non-Sulfonated): Reliable Fluorescent Labeling in Cell Assays" provides a comprehensive overview of best practices and robust data using SKU A8100.

Advanced Applications: From Organelle Degradation to Multiplexed Imaging

Beyond classic protein and peptide fluorescent labeling, Cy3 NHS ester (non-sulfonated) has been instrumental in advanced biomedical and translational research. A landmark study, "Modular Nanoassemblies Mimicking p62 Aggregates for Targeted Organelle Sequestration and Degradation against Breast Cancer", harnesses fluorescent labeling to track and validate nanoparticle-mediated autophagy for selective organelle clearance. In this study, fluorescently labeled peptides and proteins, tagged with Cy3 analogs, enabled real-time imaging of NanoTACOrg assemblies as they clustered and degraded mitochondria, ER, and Golgi apparatus. This visualization was critical for confirming the mechanism of action and spatiotemporal dynamics of organelle degradation, ultimately correlating molecular events with cellular outcomes in breast cancer models.

Compared to water-soluble sulfo-Cy3 derivatives, the non-sulfonated Cy3 NHS ester offers higher solubility in organic solvents and greater compatibility with hydrophobic biomolecules or nanoparticles—making it ideal for complex conjugations and nanoengineering. Its robust fluorescence, even in demanding environments, ensures quantitative imaging in cell viability, cytotoxicity, and metabolic studies, as highlighted in "Cy3 NHS Ester (Non-Sulfonated): Advanced Fluorescent Dye for Biomedical Imaging". Here, the authors demonstrate how Cy3 NHS ester empowers multi-color flow cytometry, super-resolution microscopy, and metabolic pathway tracing.

For researchers seeking to deepen their understanding of nanoparticle-assisted autophagy and the translational utility of fluorescent labeling, the thought-leadership article "Illuminating Organelle Degradation: Strategic Guidance for Advanced Fluorescent Labeling" extends the discussion to clinical and systems biology frontiers, complementing the workflow perspectives outlined here.

Comparative Advantages: Why Choose Cy3 NHS Ester (Non-Sulfonated) from APExBIO?

• High Sensitivity & Specificity: Extinction coefficient of 150,000 M⁻¹cm⁻¹ and quantum yield of 0.31 enable detection of low-abundance targets in complex mixtures.
• Workflow Flexibility: Soluble at ≥59 mg/mL in DMSO, facilitating concentrated stock preparation and compatibility with a wide range of protein and peptide labeling protocols.
• Multiplexed Imaging: Orange emission (570 nm) with standard TRITC filters allows seamless integration into multi-color assays without spectral overlap.
• Proven Reliability: APExBIO’s quality control ensures lot-to-lot consistency, supporting reproducible experimental results as documented in multiple peer-reviewed studies and reviews.
• Versatility: Suitable for labeling not only soluble proteins but also oligonucleotides, DNA, peptides, and nanoassemblies, empowering applications from fundamental cell biology to translational cancer research.

For a full product specification and ordering information, visit the Cy3 NHS ester (non-sulfonated) page at APExBIO.

Troubleshooting and Optimization: Ensuring Robust Fluorescent Labeling

Common Issues and Solutions

• Low Labeling Efficiency: Confirm the freshness of the Cy3 NHS ester and ensure the reaction buffer is free of Tris, glycine, or other primary amines that can compete with target biomolecules. Adjust the dye:protein ratio and ensure sufficient reaction time (30–60 min).
• Dye Aggregation or Precipitation: Insufficient solubility in aqueous buffers may cause precipitation. Always dissolve the dye in DMSO or DMF before addition; for highly sensitive proteins, consider a water-soluble sulfo-Cy3 NHS ester.
• Fluorescence Quenching: Excessive dye loading can lead to self-quenching. Optimize the degree of labeling (typically 2–6 dyes per protein molecule for best signal-to-noise ratios).
• Photobleaching: Protect samples from prolonged light exposure; work under subdued light and add anti-fade reagents if necessary.
• Batch Variability: Source from trusted suppliers like APExBIO and validate each batch using absorbance and fluorescence measurements before critical experiments.

For scenario-driven troubleshooting and further protocol recommendations, "Empowering Cell Assays with Cy3 NHS ester (non-sulfonated)" offers practical Q&A and detailed workflow enhancements for quantitative fluorescence readouts in cell-based assays.

Future Outlook: Cy3 NHS Ester in Next-Generation Biomedical Research

The versatility and sensitivity of Cy3 NHS ester (non-sulfonated) position it at the forefront of next-generation biomedical imaging fluorescent dye development. As studies like the NanoTACOrg investigation demonstrate, the ability to track dynamic organelle interactions and therapeutic outcomes in real time will be crucial for advancing cancer models, targeted degradation strategies, and metabolic profiling. The unique solubility profile and robust fluorescence of this dye will continue to empower multiplexed imaging, single-molecule studies, and nanoassembly characterization.

Looking ahead, integration with machine learning-driven image analysis and high-throughput screening platforms will further enhance the utility of Cy3 NHS ester in systems biology. Innovations in dye chemistry—such as further tuning of spectral properties and development of new conjugation strategies—are expected to expand the applicability of this orange fluorescent dye for both research and clinical diagnostics. APExBIO remains committed to supporting researchers with high-quality dyes, validated protocols, and responsive technical support for the challenges of tomorrow’s biomedical research.

Conclusion

Whether applied to protein, peptide, or oligonucleotide labeling dye workflows, Cy3 NHS ester (non-sulfonated) stands out as a foundational tool for quantitative, reproducible, and sensitive biomolecular detection. By integrating robust labeling chemistries with advanced imaging and analytical workflows, researchers can unlock new insights into cellular processes, disease mechanisms, and therapeutic interventions.